Real-World Testing Patterns for Risk Assessment and Implications on the Adoption of Novel Therapeutics in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: IGHV Mutation Status, FISH Cytogenetic, and Immunophenotyping

You are here: